Thrombotic thrombocytopenia After Sinopharm BBIBP-CorV COVID-19 vaccination.
Rezvan HosseinzadehMohammad BararyHamed MehdinezhadTerence T SioFlorian LangerSahar KhosraviPublished in: Research and practice in thrombosis and haemostasis (2022)
Our patient developed deteriorating symptoms the day after vaccination and was admitted to the emergency department on day 5 after vaccination. After performing laboratory analysis, thrombosis with thrombocytopenia was suggested, further confirmed by highly positive anti-heparin-platelet factor 4 antibodies assay and color Doppler ultrasonography. He was then treated with high-dose intravenous immunoglobulin, corticosteroid, and nonheparin anticoagulant.
Keyphrases
- high dose
- emergency department
- venous thromboembolism
- coronavirus disease
- low dose
- sars cov
- magnetic resonance imaging
- atrial fibrillation
- stem cell transplantation
- pulmonary embolism
- case report
- computed tomography
- growth factor
- blood flow
- depressive symptoms
- sleep quality
- respiratory syndrome coronavirus
- newly diagnosed
- electronic health record
- data analysis